282 results on '"Pavelka, K"'
Search Results
2. Serum biomarkers and their relationship to axial spondyloarthritis associated with inflammatory bowel diseases
3. Circulating miRNAs in hand osteoarthritis
4. A decrease in serum 1,25(OH)2D after elective hip replacement and during bone healing is associated with changes in serum iron and plasma FGF23
5. Decrease in serum calcitriol (but not free 25-hydroxyvitamin D) concentration in hip fracture healing
6. Factors associated with the orthopaedic surgeon's decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1905 patients
7. ANALYSIS OF POSSIBLE GEODETIC APPROACHES FOR 3D MODEL CREATION IN BIM.
8. DIFFERENT DATA JOINING AS A BASIC MODEL FOR HBIM – A CASE PROJECT ST. PATALEIMON IN SKOPJE.
9. MODERN METHODS OF DOCUMENTATION AND VISUALIZATION OF HISTORICAL MINES IN THE UNESCO MINING REGION IN THE ORE MOUNTAINS.
10. Efficacy evaluation of highly purified intra-articular hyaluronic acid (Sinovial ®) vs hylan G-F20 (Synvisc ®) in the treatment of symptomatic knee osteoarthritis. A double-blind, controlled, randomized, parallel-group non-inferiority study
11. The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement
12. Brief Report: Association of Rheumatoid Factor and Anti–Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis
13. Serum hyaluronic acid as a potential marker with a predictive value for further radiographic progression of hand osteoarthritis
14. Multi-language translation and cross-cultural adaptation of the OARSI/OMERACT measure of intermittent and constant osteoarthritis pain (ICOAP)
15. INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO BDMARDS: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTRIES (THE "JAK-POT" STUDY).
16. Validace české verze dotazníku hodnotícího časný záchyt střevních a mimostřevních projevů u pacientů s axiální spondyloartritidou s rizikem vývoje idiopatického střevního zánětu: screeningová kritéria IBD pro pacienty se SpA
17. Impact of clinical fractures on health-related quality of life is dependent on time of assessment since fracture: results from the FREEDOM trial
18. Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials
19. Ankylosierende Spondylitis in Mittel- und Osteuropa: Querschnittsstudie zu Behandlungsmustern, Krankheitsaktivität und Lebensqualität
20. Factors influencing health status and disability of patients with ankylosing spondylitis in the Czech Republic
21. ANALYSIS OF DATA JOINING FROM DIFFERENT INSTRUMENTS FOR OBJECT MODELLING.
22. A decrease in serum 1,25(OH)2D after elective hip replacement and during bone healing is associated with changes in serum iron and plasma FGF23.
23. Seronegative Lyme Arthritis caused by Borrelia garinii
24. Analysis of the Reasons for DMARD Therapy Discontinuation in Patients with Rheumatoid Arthritis in the Czech and Slovak Republics
25. COMPARISON OF LEICA BLK360 AND LEICA BLK2GO ON CHOSEN TEST OBJECTS.
26. GATHERING GEODATA FOR HBIM AND ANALYSIS ON PRESERVING A CARAVANSERAI IN KOYSENJAQ.
27. Assessment of joint space narrowing with conventional standing antero-posterior radiographs: relief in mild-to-moderate pain is not a confounder in recent osteoarthritis structure-modifying drug trials
28. Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis
29. Low circulating Dickkopf-1 and its link with severity of spinal involvement in diffuse idiopathic skeletal hyperostosis
30. Nabumetone Induces Less Gastrointestinal Mucosal Changes Than Diclofenac Retard
31. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
32. Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA
33. EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis
34. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial
35. EULAR/EFORT recommendations for the diagnosis and initial management of patients with acute or recent onset swelling of the knee
36. Increasing the infliximab dose in rheumatoid arthritis patients: a randomised, double blind study failed to confirm its efficacy
37. Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study
38. Increased serum adiponectin levels in female patients with erosive compared with non-erosive osteoarthritis
39. EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT
40. Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis
41. Dosažení cíle léčby revmatoidní artritidy je častější u pacientů se střední aktivitou než vysokou aktivitou nemoci v reálné klinické praxi národního registru biologické léčby ATTRA.
42. Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists
43. Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum
44. EULAR evidence based recommendations for the management of hand osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
45. Consensus statement on the use of rituximab in patients with rheumatoid arthritis
46. Sustained benefit in rheumatoid arthritis following one course of rituximab: improvements in physical function over 2 years
47. S100A4 is expressed at site of invasion in rheumatoid arthritis synovium and modulates production of matrix metalloproteinases
48. Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison
49. ASAS/EULAR recommendations for the management of ankylosing spondylitis
50. An unusual clinical manifestation of secondary Sjögren's syndrome and concomitant Paterson-Kelly syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.